BRAV3:BMFBOVESPABrava Energia SA Analysis
Data as of 2026-05-18 - not real-time
R$19.17
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Brava Energia trades around R$19.17, well below its DCF-derived fair value of R$39.23, implying an upside of roughly 25% if the model holds. The stock’s trailing P/E of 39.1x is markedly higher than the energy industry average of 22x, yet the forward P/E collapses to 3.5x thanks to a sharp rise in projected EPS, signaling strong earnings acceleration. Revenue growth of 9% and a gross margin near 27% demonstrate solid top‑line performance, but the company’s debt‑to‑equity ratio exceeds 170% and ROE is only 2%, raising concerns about balance‑sheet resilience and capital efficiency.
Technically, the price sits above the 20‑day SMA (18.76) but below the 50‑day SMA (19.26), with a neutral trend and a modest bullish MACD histogram (+0.036) and RSI at 53, suggesting limited short‑term momentum. Volume is decreasing and 30‑day volatility is high at over 40%, while beta is near zero, indicating the stock moves largely independent of broader market swings. The recent announcement that Ecopetrol is acquiring an equity stake could provide a strategic partnership boost, adding a catalyst to the otherwise subdued price action.
Technically, the price sits above the 20‑day SMA (18.76) but below the 50‑day SMA (19.26), with a neutral trend and a modest bullish MACD histogram (+0.036) and RSI at 53, suggesting limited short‑term momentum. Volume is decreasing and 30‑day volatility is high at over 40%, while beta is near zero, indicating the stock moves largely independent of broader market swings. The recent announcement that Ecopetrol is acquiring an equity stake could provide a strategic partnership boost, adding a catalyst to the otherwise subdued price action.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering near support at R$17.24
- Bullish MACD histogram but decreasing volume
- High short‑term volatility (~41%)
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF upside of ~25% and low forward P/E
- Ecopetrol equity stake announcement as a catalyst
- Strong earnings growth outlook (forward EPS) and low beta
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Elevated debt‑to‑equity ratio and modest ROE
- Sustained dividend at 0.66% with zero payout ratio
- Sector cyclicality and exposure to Brazilian regulatory environment
Key Metrics & Analysis
Financial Health
Revenue Growth9.10%
Profit Margin1.96%
P/E Ratio39.1
ROE2.06%
ROA3.32%
Debt/Equity173.81
P/B Ratio0.8
Op. Cash FlowR$4.9B
Free Cash FlowR$1.7B
Industry P/E22.0
Technical Analysis
TrendNeutral
RSI53.2
SupportR$17.24
ResistanceR$21.46
MA 20R$18.76
MA 50R$19.26
MA 200R$17.62
MACDBullish
VolumeDecreasing
Fear & Greed Index89.61
Valuation
Fair ValueR$39.24
Target PriceR$23.95
Upside/Downside24.96%
GradeUndervalued
TypeBlend
Dividend Yield0.66%
Risk Assessment
Beta0.10
Volatility41.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.